Biotech teams waste weeks designing control groups and variable matrices for common experiment types. AI can suggest optimized designs.
Create a marketplace of vetted experimental templates for PCR, cell culture, etc., with adjustable parameters and estimated resource needs.
Sell to academic labs and small biotechs via tiered subscriptions.
Start with 10 most-cited protocols in synthetic biology.
Risk is labs being reluctant to trust external templates.